Research Paper Volume 13, Issue 10 pp 13926—13940

Peroxiredoxin II with dermal mesenchymal stem cells accelerates wound healing

class="figure-viewer-img"

Figure 6.

Expression of cell-growth factors in DMSCs. (A) Fragments per kilobase of transcript per million mapped reads values obtained by RNA-sequencing analysis. (B, C) Relative expression levels of four genes in DMSCs with and without Prx II expression, as determined by RT-PCR, are shown. (D) Proliferation of dermal fibroblasts after treatment with Prx II+/+ DMSC-CM or Prx II−/− DMSC-CM. ***p < 0.001, when compared with the control group.